| Name |
Recombinant Human AICL/CLEC-2B Fc Chimera Protein, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9059-CL
|
| Category |
Protein
|
| Prices |
$339.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
Chinese Hamster Ovary cell line, CHO-derived MD Human IgG 1 (Pro100-Lys330) IEGR Human AICL/CLEC-2B (Lys26-His149) with a Met79Thr substitution Accession # Q92478 N-terminus C-terminus
|
| Purity |
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its binding ability in a functional ELISA. When Recombinant Human AICL/CLEC-2B Fc Chimera is coated at 2 µg/mL (100 µL/well), the concentration of Recombinant Human Galectin-1 (Catalog # 1152-GA) that produces 50% optimal binding response is 0.6-3 µg/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| Gene |
CLEC2B
|
| Sequence |
Met
|
| Supplier Page |
Shop
|
When Recombinant HumanAICL/CLEC-2B Fc Chimera (Catalog # 9059-CL) is coated at 2 µg/mL, Recombinant Human Galectin-1(Catalog # 1152-GA) binds with a typical ED 50 of 0.6-3 µg/mL.